How will I know if my Liver Cancer treatment is working

How to Know If Your Liver Cancer Treatment Is Working

This is one of the most important questions you can ask your care team. Monitoring treatment response helps your doctors decide whether to continue, adjust, or change your approach. Let me explain how doctors assess this.

How Doctors Measure Treatment Response

According to the NCCN Guidelines for Hepatocellular Carcinoma, doctors use several methods to evaluate whether treatment is working:

1. Imaging Studies (The Primary Tool)

Your doctors will use imaging scans to look directly at your tumors and see if they're shrinking, staying the same, or growing. The main imaging methods include:

• CT scans (computed tomography) - detailed X-ray images of your liver
• MRI scans - magnetic imaging that shows liver tissue in detail
• Ultrasound - sound wave imaging (less sensitive but often used for follow-up)

Timing: According to NCCN Guidelines, imaging is typically done every 3-6 months for the first 2 years, then every 6 months after that.

2. AFP Blood Test (Alpha-Fetoprotein)

AFP is a protein that liver cancer cells often produce. Your doctors will check your AFP levels regularly because:

• Dropping AFP levels generally suggest the cancer is responding to treatment
• Rising AFP levels may indicate the cancer is progressing

According to NCCN Guidelines, AFP should be checked on the same schedule as imaging: every 3-6 months for 2 years, then every 6 months.

3. Special Response Criteria for Liver Cancer

Because liver cancer responds differently to treatment than other cancers, doctors use specialized measurement systems:

• mRECIST (modified Response Evaluation Criteria in Solid Tumors) - specifically designed for HCC
• RECIST 1.1 - standard measurement criteria

These systems measure whether tumors have:

• Completely disappeared (complete response)
• Significantly shrunk (partial response)
• Stayed about the same (stable disease)
• Grown (progressive disease)

What "Working" Means in Different Situations

The definition of treatment success depends on your specific situation:

For early-stage disease (resectable or transplant candidates):

• Goal is often complete elimination or significant shrinkage to make surgery/transplant possible

For advanced disease:

• "Working" may mean slowing growth, preventing spread, or extending survival time
• Even stable disease (no growth) can be considered a positive response

For locoregional therapy (like chemoembolization or radiation):

• Doctors look for tumor necrosis (cell death) within the treated area
• AFP response is also important

Important Signs to Discuss With Your Team

Beyond imaging and blood tests, tell your doctor about:

• Symptom changes - improvement in fatigue, pain, or abdominal swelling
• Energy levels - whether you feel stronger or weaker
• Appetite and weight - stable or improving weight is generally positive
• Side effects - how you're tolerating treatment

What Happens If Treatment Isn't Working

According to NCCN Guidelines, if imaging shows progression (growth) on your current treatment, your care team may:

• Reconsider locoregional therapy (ablation, chemoembolization, radiation)
• Switch to subsequent-line systemic therapy (different chemotherapy or immunotherapy)
• Explore clinical trials
• Transition to best supportive/palliative care if appropriate

Questions to Ask Your Oncology Team

1. When will we do the first imaging to assess response, and how often after that?
2. What specific response criteria will you use to measure my treatment success?
3. What AFP level would you consider a good response for my situation?
4. What counts as "working" for my specific stage and type of treatment?
5. If my scans show progression, what are the next treatment options?
6. How will we monitor my liver function during treatment? (This is important because your liver's ability to handle treatment matters)
7. Are there any clinical trials I should consider if my current treatment stops working?

Liver Function Matters

An important point from NCCN Guidelines: Your liver's overall health (called your Child-Turcotte-Pugh score or CTP score) affects both how well treatment works and how well you tolerate it. Your doctors should be monitoring:

• Albumin levels (protein your liver makes)
• Bilirubin (bile pigment)
• Clotting ability
• Signs of portal hypertension (fluid buildup, enlarged spleen)

This is why regular blood work alongside imaging is so important.

Key Takeaway

Treatment response is measured through a combination of imaging scans, blood tests (especially AFP), and how you're feeling. Your care team should have a clear plan for when and how they'll assess your response, and they should discuss what "success" looks like for YOUR specific situation. Don't hesitate to ask for clear explanations of your scan results and what they mean for your next steps.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.